[HTML][HTML] Development of small-molecule MERS-CoV inhibitors

R Liang, L Wang, N Zhang, X Deng, M Su, Y Su, L Hu… - Viruses, 2018 - mdpi.com
Middle East respiratory syndrome coronavirus (MERS-CoV) with potential to cause global
pandemics remains a threat to the public health, security, and economy. In this review, we …

[HTML][HTML] Mortality rate of ICU patients with the Middle East respiratory syndrome-coronavirus infection at King Fahad Hospital, Jeddah, Saudi Arabia

MA Garout, HAA Jokhdar, IA Aljahdali… - … European journal of …, 2018 - cejph.szu.cz
Objective: The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a novel
coronavirus circulating in the Arabian Peninsula since September 2012. It leads to …

In silico studies on novel inhibitors of MERS-CoV: Structure-based pharmacophore modeling, database screening and molecular docking

AA Radwan, FK Alanazi - Tropical Journal of Pharmaceutical Research, 2018 - ajol.info
Purpose: To search for novel scaffolds as potential inhibitors of 3CLpro protease enzyme
and as antiviral drugs. Methods: NCI database was screened using structure-based …

[PDF][PDF] MERS-CoV: Identifying Viral and Host Factors Associated with Transmission, Pathogenesis, and Treatment Development

H Rahman - Jemi Pearls, 2018 - jemi.microbiology.ubc.ca
Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel betacoronavirus that
is associated with a high mortality rate (~ 36%) and is endemic in the Middle East. Since …

Microflore rhizosphérique de quelques fabacées (légumineuses) endémiques dans les régions de Boussaâda et de Biskra Algérie

M Ghadbane - 2018 - dspace.univ-setif.dz
L'activité antimicrobienne, l'effet phytostimulateur et les modes d'action des rhizobactéries
isolées à partir de trois Fabacées endémiques d'Algérie (Ononis angustissima, Astragalus …